dc.contributor.author
Keshi, Eriselda
dc.contributor.author
Tang, Peter
dc.contributor.author
Weinhart, Marie
dc.contributor.author
Everwien, Hannah
dc.contributor.author
Moosburner, Simon
dc.contributor.author
Seiffert, Nicolai
dc.contributor.author
Lommel, Michael
dc.contributor.author
Kertzscher, Ulrich
dc.contributor.author
Globke, Brigitta
dc.contributor.author
Reutzel-Selke, Anja
dc.contributor.author
Strücker, Benjamin
dc.contributor.author
Pratschke, Johann
dc.contributor.author
Sauer, Igor Maximillian
dc.contributor.author
Haep, Nils
dc.contributor.author
Hillebrandt, Karl Herbert
dc.date.accessioned
2023-03-13T13:28:54Z
dc.date.available
2023-03-13T13:28:54Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/38342
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-38061
dc.description.abstract
Background: Since autologous veins are unavailable when needed in more than 20% of cases in vascular surgery, the production of personalized biological vascular grafts for implantation has become crucial. Surface modification of decellularized xenogeneic grafts with vascular cells to achieve physiological luminal coverage and eventually thromboresistance is an important prerequisite for implantation. However, ex vivo thrombogenicity testing remains a neglected area in the field of tissue engineering of vascular grafts due to a multifold of reasons.
Methods: After seeding decellularized bovine carotid arteries with human endothelial progenitor cells and umbilical cord-derived mesenchymal stem cells, luminal endothelial cell coverage (LECC) was correlated with glucose and lactate levels on the cell supernatant. Then a closed loop whole blood perfusion system was designed. Recellularized grafts with a LECC > 50% and decellularized vascular grafts were perfused with human whole blood for 2 h. Hemolysis and complete blood count evaluation was performed on an hourly basis, followed by histological and immunohistochemical analysis.
Results: While whole blood perfusion of decellularized grafts significantly reduced platelet counts, platelet depletion from blood resulting from binding to re-endothelialized grafts was insignificant (p = 0.7284). Moreover, macroscopic evaluation revealed thrombus formation only in the lumen of unseeded grafts and histological characterization revealed lack of CD41 positive platelets in recellularized grafts, thus confirming their thromboresistance.
Conclusion: In the present study we were able to demonstrate the effect of surface modification of vascular grafts in their thromboresistance in an ex vivo whole blood perfusion system. To our knowledge, this is the first study to expose engineered vascular grafts to human whole blood, recirculating at high flow rates, immediately after seeding.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Decellularization
en
dc.subject
Recellularization
en
dc.subject
Vascular graft
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Surface modification of decellularized bovine carotid arteries with human vascular cells significantly reduces their thrombogenicity
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
26
dcterms.bibliographicCitation.doi
10.1186/s13036-021-00277-2
dcterms.bibliographicCitation.journaltitle
Journal of Biological Engineering
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
15
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34819102
dcterms.isPartOf.eissn
1754-1611